Matthew E. Hardee - Concepedia

Author

Matthew E. Hardee

University of Arkansas for Medical Sciences

Also Known As

Hardee, Matthew E., M E Hardee, M Hardee, M. E. Hardee, M. Hardee, M.E. Hardee, Matthew E Hardee, Matthew E. Hardee, Matthew Hardee, Raleigh, James A.

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Arkansas for Medical Sciences Duke Medical Center New York University Winthrop Rockefeller Foundation University of North Carolina at Chapel Hill

About

Matthew E. Hardee is an author at University of Arkansas for Medical Sciences specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	480
2	Health Sciences	5	5	140
3	Engineering	2	2	111
4	Biomedical Engineering	2	2	111
5	Cell Biology	1	1	58

Matthew E. Hardee

Publications

Citations

H-Index

Page 1

	Year	Citations
Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β Matthew E. Hardee, Ariel E. Marciscano, Christina M. Medina-Ramirez, Cancer Research	2012	236
Nipple Skin-Sparing Mastectomy is Feasible for Advanced Disease Eric C. Burdge, James C. Yuen, Matthew E. Hardee, Annals of Surgical Oncology Mast Cell DisorderNipple Skin-sparing MastectomyBreast CancerSurgeryBreast Surgery	2013	107
Erythropoietin Blockade Inhibits the Induction of Tumor Angiogenesis and Progression Matthew E. Hardee, Yiting Cao, Ping Fu, PLoS ONE	2007	99
Spectral imaging facilitates visualization and measurements of unstable and abnormal microvascular oxygen transport in tumors Brian S. Sorg, Matthew E. Hardee, Nikita Agarwal, Journal of Biomedical Optics EngineeringOncologic ImagingMicroscopyBiomedical EngineeringTissue Imaging	2008	95
Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models Nathan A. Koonce, Charles M. Quick, Matthew E. Hardee, International Journal of Radiation OncologyBiologyPhysics Radiation Therapy ResultsNanomedicineSynergistic Antitumor ResponseNanotherapeuticsMurine Carcinoma Models	2015	64
Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis Matthew E. Hardee, John P. Kirkpatrick, Shengzhou Shan, British Journal of Cancer	2005	62
Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating <i>in vivo</i> chemosensitivity Matthew E. Hardee, Zahid N. Rabbani, Murat O. Arcasoy, Molecular Cancer Therapeutics Chemoprevention StrategyTumor Growth DelayApoptosisCell DeathCancer Biology	2006	58
Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification Zahid N. Rabbani, Matthew E. Hardee, S J Kim, British Journal of Cancer	2012	51
Prone Hypofractionated Whole-Breast Radiotherapy Without a Boost to the Tumor Bed: Comparable Toxicity of IMRT Versus a 3D Conformal Technique Matthew E. Hardee, Shahzad Raza, S Becker, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation MedicineMedical ImagingRadiation TherapyMedicine	2011	49
Application of Spatially Fractionated Radiation (GRID) to Helical Tomotherapy using a Novel TOMOGRID Template Xiaomin Zhang, José Peñagarícano, Yulong Yan, Technology in Cancer Research & Treatment Spatially Fractionated RadiationSurgeryAvailable Grid BlockOncologyBrachytherapy	2013	34

Page 1